{"id":"NCT03379727","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.","officialTitle":"An Open-label, Multi-Center, Phase IIIb Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia Who Are Eligible for \"7+3\" or \"5+2\" Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-02-13","primaryCompletion":"2021-07-09","completion":"2021-07-09","firstPosted":"2017-12-20","resultsPosted":"2024-02-08","lastUpdate":"2024-02-29"},"enrollment":301,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Myeloid Leukemia"],"interventions":[{"type":"DRUG","name":"Midostaurin","otherNames":["PKC412"]},{"type":"DRUG","name":"Cytarabine","otherNames":[]},{"type":"DRUG","name":"anthracycline ((daunorubicin or idarubicin): Induction Phase only","otherNames":[]}],"arms":[{"label":"Midostaurin","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to gather and evaluate additional safety and efficacy data on the combination of midostaurin and standard of care for adult patients with newly diagnosed Fms-like tyrosine kinase receptor (FLT3) mutated Acute Myeloid Leukemia (AML) who were eligible for standard induction and consolidation","primaryOutcome":{"measure":"Percentage of Patients With Adverse Events (AEs), Grade 3 & 4 AEs, Serious Adverse Events (SAEs), AEs Leading to Discontinuation, and Deaths up to 24 Months (M24).","timeFrame":"Baseline up to approximatly 24 months","effectByArm":[{"arm":"Midostaurin","deltaMin":295,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":86,"countries":["Bulgaria","Croatia","Czechia","Estonia","Finland","France","Hungary","Italy","Lithuania","Norway","Romania","Serbia","Slovakia","Spain","Sweden"]},"refs":{"pmids":["37581981"],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=1103"]},"adverseEventsSummary":{"seriousAny":{"events":76,"n":301},"commonTop":["Pyrexia","Nausea","Diarrhoea","Febrile neutropenia","Neutropenia"]}}